Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Cash Flow Statement
Cash Flow Statement
Adaptimmune Therapeutics PLC
Jun-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||||||||||||
Net Income |
(24)
|
(31)
|
(33)
|
(38)
|
(56)
|
(72)
|
(78)
|
(76)
|
(58)
|
(70)
|
(69)
|
(93)
|
(87)
|
(96)
|
(102)
|
(99)
|
(144)
|
(137)
|
(138)
|
(127)
|
(123)
|
(130)
|
(140)
|
(149)
|
(156)
|
(158)
|
(171)
|
(176)
|
(175)
|
(165)
|
(114)
|
(91)
|
(95)
|
(114)
|
|
Depreciation & Amortization |
1
|
2
|
1
|
2
|
2
|
3
|
4
|
4
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
6
|
6
|
6
|
7
|
7
|
7
|
7
|
6
|
6
|
7
|
8
|
10
|
|
Stock-Based Compensation |
7
|
0
|
0
|
0
|
0
|
9
|
12
|
14
|
17
|
11
|
13
|
14
|
15
|
16
|
15
|
14
|
12
|
11
|
9
|
8
|
10
|
10
|
14
|
17
|
19
|
21
|
21
|
20
|
19
|
18
|
14
|
13
|
13
|
0
|
|
Other Non-Cash Items |
4
|
(4)
|
7
|
3
|
5
|
8
|
10
|
7
|
4
|
3
|
(1)
|
15
|
22
|
29
|
29
|
22
|
17
|
12
|
13
|
7
|
12
|
13
|
22
|
25
|
26
|
28
|
25
|
26
|
20
|
19
|
15
|
(10)
|
(10)
|
(12)
|
|
Cash Taxes Paid |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
4
|
|
Change in Working Capital |
(14)
|
0
|
(10)
|
(2)
|
(2)
|
13
|
6
|
6
|
19
|
7
|
(9)
|
(20)
|
(37)
|
(45)
|
(28)
|
(23)
|
(13)
|
5
|
57
|
61
|
66
|
56
|
(7)
|
(6)
|
(28)
|
135
|
142
|
137
|
138
|
(2)
|
(32)
|
(33)
|
(28)
|
(25)
|
|
Cash from Operating Activities |
(33)
N/A
|
(33)
+0%
|
(36)
-9%
|
(35)
+1%
|
(51)
-44%
|
(48)
+5%
|
(58)
-20%
|
(59)
-3%
|
(31)
+49%
|
(54)
-78%
|
(73)
-35%
|
(91)
-24%
|
(94)
-4%
|
(104)
-11%
|
(93)
+11%
|
(92)
+1%
|
(132)
-43%
|
(113)
+15%
|
(59)
+47%
|
(50)
+16%
|
(37)
+26%
|
(54)
-45%
|
(117)
-118%
|
(124)
-6%
|
(152)
-23%
|
11
N/A
|
3
-73%
|
(7)
N/A
|
(10)
-43%
|
(142)
-1 335%
|
(125)
+12%
|
(127)
-2%
|
(124)
+2%
|
(141)
-13%
|
|
Investing Cash Flow | |||||||||||||||||||||||||||||||||||
Capital Expenditures |
(5)
|
(15)
|
(6)
|
(4)
|
(6)
|
(13)
|
(23)
|
(30)
|
(30)
|
(25)
|
(14)
|
(7)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(9)
|
(15)
|
(22)
|
(30)
|
(30)
|
(25)
|
(17)
|
(7)
|
(5)
|
|
Other Items |
(55)
|
(34)
|
(37)
|
(1)
|
7
|
31
|
28
|
(43)
|
(39)
|
(101)
|
(75)
|
10
|
1
|
(13)
|
(10)
|
(12)
|
22
|
98
|
8
|
(198)
|
(261)
|
(276)
|
(181)
|
55
|
118
|
85
|
64
|
67
|
70
|
119
|
167
|
118
|
137
|
181
|
|
Cash from Investing Activities |
(60)
N/A
|
(49)
+18%
|
(43)
+13%
|
(5)
+88%
|
1
N/A
|
18
+2 120%
|
6
-68%
|
(73)
N/A
|
(69)
+5%
|
(126)
-82%
|
(90)
+29%
|
4
N/A
|
(5)
N/A
|
(17)
-245%
|
(13)
+23%
|
(15)
-13%
|
19
N/A
|
95
+404%
|
5
-94%
|
(200)
N/A
|
(263)
-31%
|
(279)
-6%
|
(185)
+34%
|
49
N/A
|
112
+126%
|
76
-32%
|
49
-35%
|
46
-7%
|
40
-13%
|
89
+125%
|
142
+60%
|
101
-29%
|
129
+28%
|
177
+37%
|
|
Financing Cash Flow | |||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
275
|
176
|
176
|
0
|
0
|
0
|
61
|
103
|
104
|
104
|
44
|
3
|
103
|
103
|
101
|
101
|
0
|
0
|
92
|
339
|
340
|
340
|
249
|
4
|
3
|
3
|
3
|
10
|
12
|
13
|
13
|
3
|
2
|
1
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
275
N/A
|
176
-36%
|
176
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
61
+307 000%
|
103
+68%
|
104
+0%
|
104
0%
|
44
-58%
|
3
-94%
|
103
+3 577%
|
103
+0%
|
101
-1%
|
101
-1%
|
0
-100%
|
0
-21%
|
92
+24 703%
|
339
+270%
|
340
+0%
|
340
+0%
|
249
-27%
|
4
-99%
|
3
-9%
|
3
-2%
|
3
-15%
|
10
+264%
|
12
+13%
|
13
+12%
|
13
+1%
|
3
-76%
|
2
-28%
|
1
-60%
|
|
Change in Cash | |||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
10
|
(1)
|
(4)
|
(4)
|
(6)
|
(3)
|
0
|
1
|
2
|
2
|
4
|
4
|
3
|
2
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
(5)
|
(5)
|
(2)
|
(0)
|
4
|
5
|
1
|
|
Net Change in Cash |
182
N/A
|
105
-42%
|
96
-8%
|
(44)
N/A
|
(54)
-24%
|
(36)
+34%
|
6
N/A
|
(29)
N/A
|
5
N/A
|
(75)
N/A
|
(117)
-57%
|
(80)
+32%
|
8
N/A
|
(16)
N/A
|
(3)
+79%
|
(8)
-126%
|
(114)
-1 410%
|
(18)
+85%
|
36
N/A
|
88
+141%
|
39
-55%
|
7
-83%
|
(54)
N/A
|
(72)
-33%
|
(38)
+47%
|
90
N/A
|
54
-40%
|
44
-18%
|
36
-19%
|
(42)
N/A
|
30
N/A
|
(19)
N/A
|
12
N/A
|
37
+202%
|
|
Free Cash Flow | |||||||||||||||||||||||||||||||||||
Free Cash Flow |
(38)
N/A
|
(48)
-27%
|
(41)
+14%
|
(39)
+6%
|
(56)
-45%
|
(61)
-8%
|
(81)
-32%
|
(90)
-12%
|
(61)
+33%
|
(79)
-31%
|
(88)
-10%
|
(97)
-11%
|
(100)
-3%
|
(109)
-9%
|
(97)
+11%
|
(96)
+1%
|
(134)
-40%
|
(116)
+14%
|
(62)
+47%
|
(52)
+16%
|
(39)
+25%
|
(57)
-44%
|
(121)
-114%
|
(129)
-6%
|
(158)
-23%
|
2
N/A
|
(12)
N/A
|
(29)
-145%
|
(40)
-40%
|
(172)
-326%
|
(150)
+13%
|
(145)
+3%
|
(132)
+9%
|
(146)
-11%
|